Metformin, the go-to drug for patients diagnosed with type 2 diabetes mellitus (T2DM), may help control glycated hemoglobin (A1C) levels, but it does not help prevent heart failure in heart attack patients who do not have the disease, according to a new study from the Netherlands.
Bariatric surgery has more powerful long-term effects on controlling type 2 diabetes mellitus (T2DM) that medical therapy alone, according to the largest, long-term study comparing methods.
Should patients with moderately elevated levels of triglycerides be treated, even while cardiologists await the results of a trial that may provide a definitive answer?
From a session called How to Navigate the Maze of Pharmacotherapy in Diabetes? to oral abstracts and posters, the relationship between cardiac risks and rising incidence of type 2 diabetes mellitus received plenty of attention Saturday at the 63rd Scientific Sessions of the American College of Cardiology, being held in Washington, DC.
Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center, highlights why stakeholders should attend the Patient-Centered Diabetes Care: Putting Theory into Practice event on April 10-11, in Princeton, NJ.
Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.
Accountable care organizations (ACOs) and other population health initiatives cannot succeed without health information being able to flow between healthcare organizations and providers.
Will Share Personal Account of Managing Condition at AJMC Event: Patient-Centered Diabetes Care: Putting Theory into Practice
'In order to get technology to truly work for physicians, it must drive productivity'
Decreased out-of-pocket spending on prescription drugs accounts for reduced financial burden of care to patients, and is consistent with improved access to care.
New research offers high-quality, empirical data on the V-BID plan features that appear most effective for stimulating greater medication adherence.
Can a diabetic's likelihood of developing complications depend on picking the right doctor? A study suggests it can.
Joslin's Dr. Robert Gabbay, USC's Dr. Geoffrey Joyce, and UnitedHealthcare's Dr. Deneen Vojta are among the lineup of national speakers coming to the Princeton Marriott at Forrestal April 10-11.
Drugstore giant CVS Caremark's decision to stop selling tobacco products at its stores is being hailed as a victory among public health advocates, a move they predict will force CVS competitors to follow suit as they look to play a growing part in the delivery of the country's healthcare.
Dr. Robert Gabbay of Joslin Diabetes Center will offer the keynote address at Patient-Centered Diabetes Care 2014 on April 10-11 at the Princeton Marriott at Forrestal.
